Answers are grounded in this paper and cite their sources.
The frequency of primary resistance to NNRTIs is increasing, although resistance to all available classes of antiretroviral therapy remains rare. Genotypic resistance testing in recently infected persons predicts time to viral suppression during therapy.
No takes yet. Share an insight, caveat, or question.
Robert M. Grant (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: